Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$338,515
+$4,757 QoQ
Shares Held
2,160
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,066
of 1,603 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $33,612,604 across 12 Drug Manufacturers - General names. NVS ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,377 | $11,247,056 | |
| 2 | ABBV |
AbbVie Inc.
|
22,380 | $5,631,703 | |
| 3 | JNJ |
Johnson & Johnson
|
20,128 | $5,111,908 | |
| 4 | MRK |
Merck & Co., Inc.
|
29,013 | $3,728,170 | |
| 5 | PFE |
Pfizer Inc
|
94,107 | $2,266,096 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
34,471 | $1,986,219 | |
| 7 | AMGN |
Amgen Inc
|
4,406 | $1,595,500 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,409 | $809,713 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $338,515 | 2,160 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $333,758 | 2,185 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $292,422 | 2,121 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $211,596 | 1,650 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $204,143 | 1,687 | Shares | Sole | 2025-08-04 | |
| 2021-03-31 | $208,913 | 2,444 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $234,941 | 2,488 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $216,356 | 2,488 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $306,301 | 3,507 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||